-- 据《澳大利亚金融评论报》周二援引匿名交易参与者的消息报道，Codan（ASX：CDA）的最大个人股东、亿万富翁帕梅拉·沃尔(Pamela Wall)已批准一笔价值约3亿澳元的大宗交易。 据报道，此次减持后，沃尔仍将持有价值约12亿澳元的Codan股票。 据悉，Canaccord Genuity正在负责此次交易。报道称，此次交易的股票发行价约为每股39澳元。 （市场动态新闻来源于与全球市场专业人士的对话。我们认为这些信息来自可靠渠道，但可能包含传闻和猜测。我们无法保证其准确性。）
Related Articles
Asia
Smartgroup Welcomes Australian Government Decision to Maintain Electric Car Discount for a Year, Shares Reach Two-Year Peak
Smartgroup (ASX:SIQ) welcomes a decision by the Australian government to maintain the electric car discount for another year, according to a Tuesday statement.It noted that the policy provides certainty for the charging industry, supporting further investment in Australia's charging infrastructure and helping build the network needed for broader electric vehicle adoption.Its shares jumped 7% in recent trading, reaching a two-year peak.
$ASX:SIQ
Asia
Market Chatter: Qantas CEO Becoming 'More Optimistic' on Fuel Supply
Qantas Airways (ASX:QAN) Chief Executive Vanessa Hudson said the company is becoming "more optimistic" on fuel supply, Bloomberg News reported Tuesday.Speaking at the Macquarie Australia Conference, Hudson said the company has fuel commitments up to the middle of June, per the report.Hudson noted that the airline registered strong demand for domestic and international air travel despite high fuel prices.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
$ASX:QAN
Asia
Sigma Healthcare Says Chemist Warehouse Brand to Enter UK Under Agreement With Pharmacy Group; Shares Rise 4%
Sigma Healthcare (ASX:SIG) said Tuesday signed a memorandum of understanding with Greenlight Healthcare, under which the Chemist Warehouse brand will enter the UK market.The company said in a statement that it will acquire a 75% interest in a number of stores of the employee-owned pharmacy group, with 25% continuing to be held by GreenLight.Sigma will license the Chemist Warehouse brand and intellectual property, and provide retail support, while GreenLight will provide the dispensary and professional services requirements as well as back office support.The first phase of the joint venture will focus on rebranding and developing up to five stores initially, with the first site to be in Hoxton Street, northeast of the city of London. If the first phase proves to be successful, more stores could be developed in the second phase. The parties plan to identify existing GreenLight pharmacies and where appropriate develop or relocate these into Chemist Warehouse stores.Sigma Healthcare's shares rose nearly 4% in recent trading on Tuesday.
$ASX:SIG